Corticosterone mediates the effects of chronic stress on Theiler's virus in mice by Satterlee, Danielle Marie
CORTICOSTERONE MEDIATES THE EFFECTS OF CHRONIC STRESS 
ON THEILER'S VIRUS IN MICE 
A Senior Honors Thesis 
by 
DANIELLE MARIE SATTERLEE 
Submitted to the Office of Honors Programs 
& Academic Scholarships 
Texas A&M University 
In partial fulfillment of the requirements of the 
UNIVERSITY UNDERGRADUATE 
RESEARCH FELLOWS 
April 2001 
Group: Psychology 2 
CORTICOSTERONE MEDIATES THE EFFECTS OF CHRONIC STRESS 
ON THEILER'S VIRUS IN MICE 
A Senior Honors Thesis 
by 
DANIELLE MARIE SATTERLEE 
Submitted to the Office of Honors Programs 
& Academic Scholarships 
Texas A&M University 
ln partial fulfillment of the requirements of the 
UNIVERSITY UNDERGRADUATE 
RESEARCH FELLOWS 
Approved as to style and content by: 
ary Meagher 
(Fe(lows Advisor) 
Edward A. Funkhouser 
(Executive Director) 
April 2001 
Group: Psychology 2 
ABSTRACT 
Corticosterone Mediates the Effects of 
Chronic Stress on Theiler's Virus in Mice. (April 2001) 
Danielle Marie Satterlee 
Department of Psychology 
Texas A8M University 
Fellows Advisor: Dr. Mary Meagher 
Department of Psychology 
Theiler's Murine Encephalomyelitis Virus in mice is a clinically relavant 
model of multiple sclerosis (MS) since the current hypothesis is that a viral 
infection may be the initiating event in the development of MS. Chronic 
restraint stress profoundly affects vulnerability to the acute phase of Theiler's 
virus. This study confirms that restraint results in higher mortality rates, more 
severe clinical signs and decreased body weights in mice restrained and 
infected with Thei(er's virus compared to nonstressed-infected mice. Two 
experiments identified the mediator of these effects as corticosterone, a 
stress hormone released by the HPA axis. The first experiment found that 
restraint stress elevated corticosterone levels, and the second experiment 
found that administration of exogenous corticosterone produced immune 
suppressive effects similar to restraint (mortality, increased symptomatology, 
decreased body weight). 
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1. Introduction 
A growing body of evidence supports the idea that the central nervous 
system (CNS) and the endocrine system interact to modulate immune system 
activity. The effects of stress on immune function are a good example of this 
concept. One means, by which physical and psychosocial stressors activate 
the hypothalamic pituitary adrenal (HPA) axis. Stressors cause the release of 
corticotropin releasing hormone (CRH) from the hypothalamus. This release 
then stimulates the pituitary gland to release adrenocorticotropin hormone 
(ACTH). ACTH circulates in the bloodstream and stimulates the adrenal 
cortex to release glucocorticoids, which then influence the activity of the 
various immune effector cells directly. 
The influence of stress on the immune system depends on the 
stressor's duration. Acute stress stimulates the immune system by increasing 
production and activity of immune cells and then redistributing them to the site 
of infection (Dhabar 8 McEwen, 1996). In contrast, chronic stress 
suppresses immune responses and makes the organism more vulnerable to 
infection. Evidence suggests that the stress hormone products of the HPA 
axis mediate this effect. For example, studies have shown chronic stress 
increases susceptibility to herpes simplex and influenza viruses in mice and 
that this effect is mediated by the stress hormone corticosterone (DeLano, 8 
Mallery, 1998; Sheridan, Dobbs, Jung, Chu, Konstantinos, Padgett, & Glaser, 
This thesis follows the style and format of the Journal of Neuroimmunology 
1998). These studies found that restraint stress suppressed immune 
responses including natural killer (NK) cell activity, the production of cytokines 
(IL-1'), lymphodenopathy and mononuclear cell trafficking. Glucocorticoids 
produced by the HPA axis were shown to mediate this stress-induced 
immune suppression (Sheridan 1998). 
Stress has been implicated as a contributing factor to the onset and 
progression of several autoimmune diseases in humans, including multiple 
sclerosis (MS). Victimizing approximately 1 in 2000 people in the United 
States, MS is the most common demye(inating disease of the CNS. The 
cause of the disease is presently unknown, although viral infection in early 
adulthood is thought to be an initiating event. Anecdotal reports suggest that 
life stress frequently triggers the development of MS symptoms (Grant 1993). 
Recent studies using standardized assessment of life events substantiate the 
idea that psychological stress precedes both the onset and exacerbation of 
MS symptoms in 70 to 80'/o of cases (Warren et al, 
, 1982). Psychological 
stress can be used to predict subsequent development of brain lesions in 
patients with relapsing forms of MS (Mohr, Goodkin, Boudewyn, Huang, 
Marietta, Cheuk, & Dee, 2000). The application of an acute stressor to 
healthy subjects as well as MS patients has been shown to alter immune 
function in such a way that it could potentially exacerbate autoimmune 
disease (Mohr, Goodkin, Bacchetti, Boudewyn, Huang, Marietta, Cheuk, 8 
Dee, 2000). However, studies investigating the effects of stress on MS are 
few and their results remain controversial. 
Experimentation using animal models of MS, such as Theiler's murine 
encephalomyelitis virus (TMEV) in mice, supports the contention that stress 
plays a role in the disease, Theiler's virus is a picornovirus, which in nature 
causes an acute enteric infection and occasionally paralysis. In order to 
cause demyelination similar to MS, TMEV must establish a persistent 
infection in the CNS (Welsh, Blakemore, Tonks, Borrow, 8 Nash, 1989). The 
effects of stress on the pathogenesis of Theiler's virus infection in CBA mice 
were explored by Campbell, et al. (in press). In their study, restraint stress 
suppressed the immune system and severely exacerbated the TMEV 
infection. Infected-restrained mice had a higher incidence of clinical 
symptoms and mortality than the infected-nonstressed (control) mice. 
Immunosuppression was evidenced by the reduced number of circulating 
lymphocytes, thymic atrophy, and higher viral titers present in stressed- 
infected mice. These findings suggest that these mice were unable to clear 
the virus from the CNS as effectively as mice in the infected-control group 
were. (Campbell et al, , in press). 
Previous studies have implicated viral infections as an important 
initiating event in the etiology of MS. According to the current theory, viruses 
that trigger MS are cleared from the genera( population, but in a few 
vulnerable individuals, they may be able to establish a persistent infection 
eventually resulting in the chronic demyelination characteristic of MS. Stress- 
mediated immunosuppression could be one factor contributing to individual 
vulnerability to this virus. However, scientific literature on this subject is 
lacking. As a model of MS, TMEV is unique because it consists of both an 
acute encephalitis phase, comparable to the initial viral infection, and a 
chronic phase, comparable to the autoimmune demyelinating process. The 
present study focuses on how stress effects the acute phase of TMEV in an 
effort to gain insight into the virus that hypothetically triggers MS. 
The most likely candidate for the mechanism that mediates stress- 
induced immune suppression in TMEV is elevated corticosterone resulting 
from prolonged activation of the HPA axis. In the present study, two 
experiments explored the role of corticosterone in the acute phase of TMEV 
infection. The first experiment was designed to establish a relationship 
between elevated levels of corticosterone and restraint stress. The objective 
of the second experiment was to determine if corticosterone was sufficient to 
create the pathology observed in restrained animals infected with TMEV. In 
this procedure, exogenous corticosterone was administered without stress. 
2. Methods 
2. 1 EXPERIMENT 1 
2. f. f. Subjects 
Subjects were 48 three-week old male CBA mice (Harlan Laboratory), 
The strain was chosen for its intermediate susceptibility to the BeAn strain of 
Theiler's virus. Mice were housed six per cage and maintained on a 12-hour 
light/dark cycle. Food and water was available ad libitum. To habituate the 
mice to human contact, all mice were handled for a couple of minutes each 
day for three days prior to the behavioral stress procedures. 
2. 1. 2. Acute Clinical Signs. 
Following one week of acclimation to the laboratory and handling, each 
animal was examined for the development of clinical signs indicative of acute 
neurological disease twice per week. For each mouse, body weight and 
clinical score were recorded. The clinical score was based on a numerical 
scale with zero indicating a healthy animal and higher numbers representing 
gradually increasing severity of symptoms. Scores were determined by 
assigning point values to clinical signs of illness and then summing the points 
for each animal. Subjects received half a point for each of the following: 
slightly ruffled fur, slightly hunched posture, partial grooming, slight 
lethargy/weakness, and slightly crusted/sunken eyes; they received one point 
for exhibiting each of these symptoms to a greater degree (i. e. prominently 
ruffled fur and prominently hunched). Baseline measures of body weight and 
clinical score were taken twice during the week prior to stress and infection. 
2. 1. 3. Behavioral Stress Conditions. 
Two weeks after arrival and one day prior to infection, -1 post-infection 
(pi), mice were randomly assigned to either the restraint stress (n=24) or no 
stress control (n=24) condition. Mice receiving restraint stress were placed in 
well-ventilated 60 mL plastic tubes for 12 hours (8 p, m. -8 a. m. ) five nights per 
week for four consecutive weeks. Inside the tube, the mouse could move 
forward and backward freely, but he could not turn around nor did he have 
access to food or water. Mice in the no stress control condition remained 
undisturbed in their home cages. Because previous research showed that 
food and water deprivation in the absence of restraint did not affect pathology 
in Theiler's infected mice (Campbell et. al. 
, 
in press), this group was not 
included in the present study. 
2. 1. 4. Infection 
After the first day of restraint, day 0 pi, half of the mice in the stress 
and control conditions were anesthetized with metofane and infected 
intracranially with 5 x 10" p. f. u. of the BeAn strain of Theiler's virus in a 
volume of 20 ljl. The other half were mock infected with 20 pl of PBS. 
2. 5. 5. Bleeding 
After acclimation to handling, all mice were bled (150 pl/bleed) on days 
-5, 1, 2, 7, 16, 24, and 35 pi. Bleeds occurred at the same time of day (8-11 
a. m. ) by nicking the saphenous vein of the leg. Mice were bled one at a time 
under a fume hood, less than 10 seconds following removal from the home 
cage or restraint tube. Blood samples were taken into heparinized tubes, 
placed on ice, and centrifuged. The serum was stored at -80 C until assayed. 
2. 1. 6. Corticosterone Assays. 
Corticosterone levels were measured from these serum samples by 
radioimmunoassay (ImmuChem Double Antibody Corticosterone RIA Kit, 
Biomedicals, Inc. ). 
2. 1. 7. Statistical Analyses. 
Differences in serum corticosterone levels, body weights, and clinical 
scores were analyzed using a repeated measures analysis of covariance 
(ANCOVA), entering the baseline measure as a covariate, infection status 
and behavioral condition as between group factors, and time as a within 
group factor. 
2. 2. EXPERIMENT 2 
2. 2. 1. Subjects 
Sixteen subjects, housed four per cage, of the same age, sex, and 
strain as subjects in Experiment 1 were used. 
2. 2. 2. Clinical Signs 
Body weights and clinical scores were again recorded twice each week 
for all mice beginning one week before the initiation of stress and infection. 
2. 2. 3. Exogenous Corticosterone Administration 
Mice were randomly assigned to either the corticosterone or no 
corticosterone control condition. Corticosterone-treated mice (n=8) received 
400 pg/mL corticosterone (Sigma Laboratories) in their drinking water with 2'%%d 
ethanol to keep it in solution (Jellink, Dhabar, Sakai, 8 McEwen, 1997). 
Control mice (n=8) received only 2'lo ethanol in their water. Timing of 
corticosterone administration was designed to mimic elevated corticosterone 
levels produced by the restraint schedule in experiment 1. Mice received the 
drug at 8 p. m. the day before infection (-1 pi) and it remained in their water 
bottles for four weeks. 
2. 2. 4. Infection 
On day 0 pi, all subjects were anesthetized with metophane and 
infected intracranially with 5 x 10' p. f. u. of the BeAn strain of Theiler's virus in 
a volume 20 pl. 
2. 2. 5. Serum Corticosterone Levels-Manipulation Checks 
Bleeds were scheduled for days -5, 1, and 15 pi to check that the 
corticosterone administration was effective. However, the corticosterone 
condition experienced high and rapid mortality before the third bleed could be 
performed. 
2, 2. 6. Statistical Analyses 
ANCOVA's were performed on body weight and clinical score with the 
baseline measures used as covariates, treatment condition as a between 
groups factor, and time as a within group factor. 
3. Results 
3, 1. EXPERIMENT 1 
3. 1. 1. Serum Corficosterone t eve/s 
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Fig. 1. Mean corticosterone levels (ng/ml) over time for noninfected-control, 
infected-control, noninfected-restrained, and infected-restrained mice are 
shown. The black bar indicates the period of restraint. 
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Blood samples were obtained from all animals to determine the effects 
of restraint stress and infection on corticosterone levels. A baseline bleed 
(day -5 pi) occurred four days prior to stress followed by five bleeds (days 1, 
2, 7, 16, 24 pi) during the stress period and one bleed (day -35 pi) ten days 
after the cessation of stress. To control for pre-treatment variations in serum 
corticosterone levels, an Analysis of Covariance (ANCOVA) was performed 
using baseline corticosterone as a covariate. As Fig. 1 illustrates, restraint 
stress significantly elevated corticosterone levels in both noninfected and 
infected animals, F (1, 29) = 268. 43, g&. 0001. The effect of restraint on 
corticosterone levels did not diminish across the bleeding time points (days 1, 
2, 7, 16, 24 pi), F (3, 87) = 2. 02, p&. 05. There was not a persistent elevation 
in corticosterone after the termination of restraint stress: the effect of stress 
was not significant at day 35 pi, F =. 98, p&. 05. 
Infection also produced a significant increase in serum corticosterone 
in both restrained and control animals, F (1, 29) = 5. 08, g&. 032. However, the 
interaction between restraint and infection was not significant, F (1, 29) = 1. 79, 
g&. 05. 
3. 1. 2. Mortality 
Fig. 2 depicts survival curves for each of the four conditions. Within 
the first week following infection, five of the 12 infected-restrained mice died 
while only one of the 12 noninfected-restrained mice died. No mice died in the 
control (no stress) conditions. 
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Fig. 2. The percent survival over timeis depicted for each of the four 
conditions. 
3. 1. 3. Clinical Scores 
Twice each week, all subjects were examined for signs of illness 
(ruffled fur, poor grooming, hunching, lethargy, and sunken eyes). Increasing 
clinical scores represented worsening of these symptoms. Fig. 3 compares 
the worst clinical scores for each condition during the course of the 
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Fig. 3. The mean worst clinical scores are compared for each group: 
infected-restrained (I/R), infected-control (I/C), noninfected-restrained (N/R), 
and noninfected-control (N/C). 
experiment. The highest clinical scores were exhibited by mice in the 
infected-restrained animals followed by the noninfected-restrained animals. 
The control conditions, both infected and noninfected, showed very little sign 
of disease. An Analysis of Variance (ANOVA) using each animal's worst 
clinical score showed significant effects of restraint, F (1, 44) = 77. 03, 
p&. 0001, and infection F (1, 44) = 4. 54, g&. 039. The interaction between 
stress and infection failed to reach significance F (1, 44) = 3. 84, g&. 056. 
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However, a priori planned contrasts were performed based on previous 
findings (Campell, et al. , in press) and revealed that the infected-restrained 
group was significantly more symptomatic than the other groups combined, F 
(1, 44) = 55. 18, Q&. 0001, and than the noninfected-restrained group, F (1, 44) 
= 8. 36, Q&. 006. 3. 1. 4. 
3. 1. 4. Body Weights 
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Fig. 4. Body weights (g) are depicted against time for each condition. 
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As illustrated in Fig. 4, restraint stress and infection both reduced body 
weight. A sharp decrease in weight of restrained animals occurred on day 3 
pi, after which this group was able to recover somewhat. An ANCOVA using 
baseline as a covariate confirmed that restraint stress, F (1, 35) = 248. 77, 
g&. 0001, and infection, F (1, 35) = 7. 57, g&. 009, produced significant weight 
loss over time. 
3. 2 EXPERIMENT 2 
3. 2. 1. Mortality 
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Fig. 5. Survival curves are shown for infected mice that were administered 
corticosterone and infected control mice. 
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In this experiment, all mice were infected; half received corticosterone 
in their drinking water and the other half did not. Corticosterone had a 
profound impact on the pathology of the virus. The survival curve in Fig. 5 
depicts dramatic mortality in the corticosterone-treated group. The mice in 
this group began to die day 13 pi and reached 100'io mortality by day 16 pi 
while the control mice did not experience any mortality. Fig. 5. All subjects 
receiving corticosterone died between 13 and 16 days pi. None of the control 
subjects although also infected died. 
3. 2. 2. Clinical Scores 
A comparison of corticosterone-treated and control mice in Fig. 6 
illustrates that the clinical symptoms in treated mice began to increase on day 
5 pi as the quality of their grooming began to decline. Scores increased 
rapidly over the next week as mice became very hunched and lethargic. By 
day 16, they had all died. The control mice never showed any signs of 
illness, 
Analysis of clinical scores with an ANCOVA confirmed that over time 
corticosterone administration significantly increased clinical scores, F (1, 13) = 
65. 90, D(. 0001, and day pi, F (4, 52) = 35. 88, D(. 0001. There was also a 
significant interaction between day pi and condition, F (4, 52) = 35. 88, 
D(. 0001. 
l6 
CliniCal SCOreS: EXperiment 2 ~ Corticosterone 
Control 
I 
0 
O 
V) 
ni 
O 
-5 0 5 10 15 20 
Day post-infection 
Fig. 6. Clinical scores for the corticosterone-treated and control groups are 
depicted over time. 
3. 2. 3. Body Weight 
Corticosterone administration significantly lowered body weight over 
time as depicted in Fig. 7. The body weights of control mice increased 
steadily while weights of the treated mice decreased slowly the first week 
after infection and then plummeted day 13 pi around the same time that 
17 
clinical scores began to increase. An ANCOVA showed a main effect of 
corticosterone, F (1, 6) = 63. 36, p&. 0002 and an interaction effect between 
corticosterone and day pi, F (4, 24) = 54. 51, g&. 0001. 
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Fig. 7. Body weights for both conditions are represented across time. 
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4. Conclusions 
The results of this investigation show that the effects of restraint stress 
on the pathogenesis of TMEV in CBA mice are at least partly mediated by 
elevated levels of corticosterone. In the first experiment, chronic restraint 
stress increased vulnerability to TMEV as indicated by reduced body weights, 
increased clinical scores, and higher mortality rates of the infected-restrained 
mice. Significantly elevated corticosterone levels accompanied this increased 
symptomatology in the restrained group. in the second experiment, 
exogenous corticosterone administration produced a similar pattern of results: 
increased clinical scores and mortality and decreased body weights. 
Therefore corticosterone appears to be sufficient to produce the pathology 
observed in restraint-stressed mice infected with Theiler's virus. 
This study supports previous findings that chronic restraint stress 
increases susceptibility to the acute phase of Theiler's virus infection 
(Campbell et al. , in press). Campbell et al. also found increased clinical signs 
and mortality in infected-restrained mice, although to a greater degree. This 
previous study resulted in an 80'/o mortality rate while the present study 
produced only 42'/o mortality. The difference in these findings may be 
explained by the change in the nature of restraint. The present study used 
less confining tubes, which may not have been as severe of a stressor. 
The effect of elevated corticosterone in TMEV appears to be similar to 
the role of corticosterone in other viruses, such as herpes and influenza in 
19 
mice. Elevated levels of corticosterone ensuing from restraint-stress 
exacerbates these infections by suppressing immune responses including 
natural killer (NK) cell activity, the production of cytokines (IL-1n), 
lymphodenopathy and mononuclear cell trafficking (Sheridan, 1998). In 
influenza and herpes, blocking glucocorticoid receptors with RU486 restored 
all these immune functions in restrained-infected mice indicating that 
glucocorticoids produced by the HPA axis are necessary for stress-induced 
immune suppression (Sheridan 1998). The present study provides evidence 
that corticosterone is sufficient to create the stress-induced 
immunosuppression seen in TMEV, but the question of whether it is 
necessary still remains. Administration of a corticosterone antagonist in 
conjunction with restraint-stress could answer this question. We attempted 
this procedure with RU486 (which blocks the effects of corticosterone), but it 
resulted in mortality most likely due to unckecked inflammation in the CNS. 
Personal communication with David Padgett and John Sheridan revealed that 
high mortality also results from using RU486 with an influenza model due to 
uncontrolled fluid accumulation in the lungs. 
Another model of MS in mice, experimental allergic encephalomyelitis 
(EAE), has been used to study the mechanisms, by which stress impacts 
autoimmune disease. Chronic restraint stress received prior to infection has 
been shown to profoundly suppress the clinical and pathological changes of 
EAE in mice and rats (Whitacre, Dowdell, & Griffin). This effect was partially 
reversed by the administration of RU486 in restrained mice confirming that 
glucocorticoids mediate stress-induced suppression of EAE (Dowdell, 
Gienapp, Stuckman, Wardrop, ft Whitacre, 1999). 
Stress influences EAE and TMEV in contrasting ways, due to the 
differential mechanisms through which the models effect the CNS. EAE is a 
monophasic disease, mediated by neuroantigen-specific T lymphocytes, 
which upon encountering the neuroantigen, express proinflammatory 
lymphokines, eventually recruiting additional specific and nonspecific 
inflammatory cells and establishing demyelinating lesions {Dal Canto, 
Melvold, Kim, & Miller, 1995). Glucocorticoids that ensue from activation of 
the HPA axis by stress inhibit this response and thus reduce symptoms of the 
disease {Dowdell 1999), In contrast, during the acute phase of TMEV, NK 
cells and cytokines are important elements of the immune response that are 
directed at clearing the virus from the animal's CNS. Persistence of the virus 
in the CNS is required for demyelination to occur in the later chronic phase. 
Since glucocorticoids are known to suppress these immune cells, this may be 
why stress increases vulnerablity to the acute phase of Theiler's virus as 
shown by the present study. 
The HPA axis is not the only neuroendocrine pathway that may 
mediate the effects of stress on Theiler's virus. Stress-induced activation of 
the sympathetic nervous system (SNS) may also play a significant role. The 
sympathetic stress response is initiated by the hypothalamus and causes the 
2I 
release of catecholamines from sympathetic nerve terminals and from the 
adrenal medulla. Catecholamines, such as noradrenaline, can directly effect 
immune cells. For example, noradrenaline has been shown to suppress T 
cell (CD 8) activity (Madden, Sanders, & Felten, 1995), and T cells are an 
important element of the immune response to TMEV (Welsh, et al. , 1987). 
Although the SNS has not been shown to play a major role in EAE 
suppression (Dowdell, et al. , 1999), the effects of noradrenaline on TMEV 
have not been investigated. A combination of HPA and SNS activation may 
underlie the effects of stress on Theiler's virus infection. 
Experimentation using animal models of MS reveals that the 
neuroendocrine mechanisms, by which stress may affect the development of 
the disease, are complex. Theiler's virus is a valuable tool in illuminating 
some of these mechanisms since the current hypothesis is that a viral 
infection early in life, paired with a genetic predisposition, may trigger a 
secondary misdirected immune response that could be directed either against 
myelin antigens and/or possible persistent viruses. If this hypothesis is 
correct, TMEV is a particularly useful model since it allows investigation of the 
acute phase of viral infection, which may operate similarly to the initial viral 
agent involved in MS. EAE and the TMEV chronic phase are only 
comparable to the autoimmune demyelinating disease and do not provide 
insight into mechanisms of the virus that may trigger this disease. 
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